Kraj: Wielka Brytania
Język: angielski
Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)
Flumazenil
Actavis UK Ltd
V03AB25
Flumazenil
100microgram/1ml
Solution for injection
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 15010700; GTIN: 5012617022479
Flumazenil 0.5mg/5ml PIL - UK item no: AAAC7774 print proof no: 2 origination date: 02.11.11 originated by: SA revision date: 15.11.11 revised by: sa dimensions: 148x570 pharmacode: colours/plates: approved for print/date Non Printing Colours 1. Black 2. 3. 4. 5. 6. 1. 2. 3. date sent: 07.11.11 supplier: Synthon technically app. date: 15.11.11 min pt size: TECHNICAL APPROVAL READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. t ,FFQUIJTMFBøFU:PVNBZOFFEUPSFBEJUBHBJO t *GZPVIBWFBOZGVSUIFSRVFTUJPOT BTLZPVSEPDUPSPS QIBSNBDJTU t 5IJTNFEJDJOFIBTCFFOQSFTDSJCFEGPSZPV%POPUQBTT JUPOUPPUIFST*UNBZIBSNUIFN FWFOJGUIFJSTZNQUPNT BSFUIFTBNFBTZPVST t *GBOZPGUIFTJEFFòFDUTHFUTTFSJPVT PSJGZPVOPUJDFBOZ TJEFFòFDUTOPUMJTUFEJOUIJTMFBøFU QMFBTFUFMMZPVSEPDUPS PSQIBSNBDJTU t 5IFOBNFPGZPVSNFEJDJOFJT'MVNB[FOJMTPMVUJPOGPS JOKFDUJPO XIJDIXJMMCFSFGFSSFEUPBTA'MVNB[FOJMPS A'MVNB[FOJMNHNM4PMVUJPOGPS*OKFDUJPOUISPVHIPVU UIJTMFBøFU IN THIS LEAFLET: 1 WHAT FLUMAZENIL 0.1MG/ML SOLUTION FOR INJECTION IS AND WHAT IT IS USED FOR 2 BEFORE YOU USE 3 HOW YOU USE 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE 6 FURTHER INFORMATION 1 WHAT FLUMAZENIL 0.1MG/ML SOLUTION FOR INJECTION IS AND WHAT IT IS USED FOR 'MVNB[FOJMNHNM4PMVUJPOGPS*OKFDUJPODPOUBJOTUIFBDUJWFJOHSFEJFOU øVNB[FOJM'MVNB[FOJMCFMPOHTUPBHSPVQPGNFEJDJOFTLOPXOBT CFO[PEJB[FQJOFBOUBHPOJTUT 'MVNB[FOJMJTVTFEUPSFWFSTFUIFFòFDUTPGBHSPVQPGNFEJDJOFTLOPXO BTCFO[PEJB[FQJOFT XIJDIBSFVTFEUPDBVTFEFFQTMFFQ#ZSFWFSTJOHUIF FòFDUTPGCFO[PEJB[FQJOFT JUBMMPXTUIFQBUJFOUUPCFDPNFDPOTDJPVTTP UIBUUIFZDBOCSFBUIFVOBJEFE 'MVNB[FOJMDBOCFVTFEUPQBSUMZPSDPNQMFUFMZSFWFSTFUIFFòFDUTPG CFO[PEJB[FQJOFTFEBUJPOBOEHFOFSBMBOBFTUIFTJBBGUFSNFEJDBMUFTUTBOE PQFSBUJPOTJOUIFIPTQJUBM*UJTVTFEPOJOUFOTJWFDBSFQBUJFOUTUPCSJOH BCPVUVOBJEFECSFBUIJOH*UJTBMTPVTFEUPEJBHOPTFBOEUSFBUQBUJFOUT XIPIBWFCFFO Przeczytaj cały dokument
OBJECT 1 FLUMAZENIL 0.1 MG/ML SOLUTION FOR INJECTION Summary of Product Characteristics Updated 28-Jun-2012 | Accord-UK Ltd 1. Name of the medicinal product Flumazenil 0.1 mg/ml solution for injection. 2. Qualitative and quantitative composition Each ml contains 0.1 mg flumazenil. 1 ampoule with 5 ml contains 0.5 mg flumazenil. 1 ampoule with 10 ml contains 1 mg flumazenil. Excipient: each ml of solution contains 3.8 mg sodium. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Solution for injection. Clear colourless solution. 4. Clinical particulars 4.1 Therapeutic indications Flumazenil is indicated for the complete or partial reversal of the central sedative effects of benzodiazepines. It may therefore be used in anaesthesia and in the intensive care in the following situations: _In anaesthesia_ - Termination of hypnosedative effects in general anaesthesia induced and/or maintained with benzodiazepines in hospitalized patients. - Reversal of benzodiazepine sedation in short-term diagnostic and therapeutic procedures in ambulatory patients and hospitalized patients. _In intensive care situations_ - For the specific reversal of the central effects of benzodiazepines, in order to restore spontaneous respiration. - For diagnosis and treatment of intoxications or overdose with only or mainly benzodiazepines. For the reversal of conscious sedation induced with benzodiazepines in children > 1 year of age. 4.2 Posology and method of administration Flumazenil must be administered intravenously by an anaesthesist or doctor with experience in anesthesiology. Flumazenil may be administered either undiluted or diluted. For dilution, see section 6.6. It can be administered together with other reanimation measures. Adults _Anaesthesia_ The initial dose is 0.2 mg administered i.v. in 15 seconds. If the desired degree of consciousness is not obtained within 60 seconds, a second dose of 0.1 mg can be administered. This may be repeated at 60- second intervals where necessary, up to a total dose of 1.0 mg. Th Przeczytaj cały dokument